HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

M Matsushita Selected Research

(((5- (1,1- dimethylethyl)thiazol- 2- yl)methyl)(((4- (4- (4- (1- propylbutyl)phenoxy)methyl)phenyl)thiazol- 2- yl)methyl)amino)acetic acid

4/2010Pharmacological profiles of a novel protein tyrosine phosphatase 1B inhibitor, JTT-551.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


M Matsushita Research Topics

Disease

7Neoplasms (Cancer)
10/2009 - 03/2000
6Systemic Lupus Erythematosus (Libman-Sacks Disease)
09/2015 - 01/2000
4Infections
12/2004 - 04/2001
4Glomerulonephritis
10/2001 - 03/2000
3Hemorrhage
12/2007 - 02/2000
3Cerebral Amyloid Angiopathy (Congophilic Angiopathy)
05/2005 - 04/2002
3Alzheimer Disease (Alzheimer's Disease)
05/2005 - 10/2001
3IGA Glomerulonephritis (IGA Nephropathy)
11/2001 - 03/2000
3Biliary Liver Cirrhosis (Primary Biliary Cirrhosis)
11/2001 - 08/2001
3Neoplasm Metastasis (Metastasis)
10/2001 - 10/2000
2Body Weight (Weight, Body)
06/2007 - 09/2006
2Ataxia (Dyssynergia)
04/2005 - 04/2001
2Thrombosis (Thrombus)
09/2002 - 09/2001
2Hyperplasia
12/2001 - 12/2001
2Stomach Neoplasms (Stomach Cancer)
10/2001 - 10/2000
2Anaphylaxis (Anaphylactic Shock)
01/2001 - 11/2000
2Hepatocellular Carcinoma (Hepatoma)
08/2000 - 03/2000
2Chronic Hepatitis C
04/2000 - 01/2000
2Thrombocytopenia (Thrombopenia)
04/2000 - 02/2000
1BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia)
01/2017
1Dyspepsia (Indigestion)
01/2016
1Developmental Dysplasia of the Hip
10/2014
1Chromosome Aberrations (Chromosome Abnormalities)
05/2013
1Polyps
01/2013
1Pycnodysostosis
04/2012
1Fibrosis (Cirrhosis)
11/2011
1Lupus Nephritis
11/2011
1Vocal Cord Paralysis
11/2010
1Type IIC Hereditary Motor And Sensory Neuropathy
11/2010
1Type 2 Diabetes Mellitus (MODY)
04/2010
1Peripheral Nervous System Diseases (PNS Diseases)
11/2009
1Pancreatic Neoplasms (Pancreatic Cancer)
05/2009
1Acute Liver Failure (Fulminant Hepatic Failure)
03/2008
1Atrophy
01/2008
1Lipoma (Lipomata)
01/2007
1Cataract (Cataracts)
09/2005

Drug/Important Bio-Agent (IBA)

7LectinsIBA
11/2011 - 03/2000
7Complement System Proteins (Complement)IBA
11/2011 - 01/2000
6Mannose-Binding Lectin (Mannan-Binding Lectin)IBA
11/2003 - 03/2000
3Immunoglobulin A (IgA)IBA
11/2001 - 03/2000
3AutoantigensIBA
10/2001 - 01/2000
3Proteins (Proteins, Gene)FDA Link
10/2001 - 01/2000
2CytokinesIBA
09/2015 - 01/2000
2Glucose (Dextrose)FDA LinkGeneric
04/2010 - 09/2006
2Protein Kinase C betaIBA
11/2009 - 09/2005
2Amyloid beta-PeptidesIBA
05/2005 - 06/2003
2Messenger RNA (mRNA)IBA
05/2005 - 09/2002
2NucleotidesIBA
04/2005 - 12/2000
2FicolinsIBA
12/2004 - 11/2003
2Phenobarbital (Luminal)FDA Link
07/2004 - 09/2002
2Neprilysin (Neutral Endopeptidase)IBA
06/2003 - 12/2001
2Complementary DNA (cDNA)IBA
09/2002 - 01/2000
2Immunoglobulin G (IgG)IBA
11/2001 - 06/2001
2AntibodiesIBA
11/2001 - 08/2001
2Monoclonal AntibodiesIBA
11/2001 - 06/2001
2AntigensIBA
10/2001 - 03/2001
2AutoantibodiesIBA
08/2001 - 01/2000
2Hemostatics (Antihemorrhagics)IBA
02/2001 - 02/2000
2LipopolysaccharidesIBA
01/2001 - 11/2000
22- methyl- 3- (4- phenylpiperidino)propionohydroxamic acid hydrochloride (K 76)IBA
01/2001 - 11/2000
2Type II Tumor Necrosis Factor ReceptorsIBA
12/2000 - 04/2000
2Transforming Growth Factor beta (TGF-beta)IBA
08/2000 - 03/2000
2Cytochrome P-450 CYP2D6 (CYP2D6)IBA
04/2000 - 01/2000
2HLA-DR Antigens (HLA-DR)IBA
04/2000 - 01/2000
1Tyrosine Kinase InhibitorsIBA
01/2017
1Z 338IBA
01/2016
1Biomarkers (Surrogate Marker)IBA
09/2015
1Interferon-alpha (Interferon Alfa)IBA
09/2015
1Thalidomide (Thalomid)FDA Link
05/2013
1Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
05/2013
1Cathepsin KIBA
04/2012
1Complement Factor H (Factor H)IBA
11/2011
1Complement Factor B (Factor B)IBA
11/2011
1Transient Receptor Potential ChannelsIBA
11/2010
1Non-Receptor Type 1 Protein Tyrosine PhosphataseIBA
04/2010
1Insulin (Novolin)FDA Link
04/2010
1(((5- (1,1- dimethylethyl)thiazol- 2- yl)methyl)(((4- (4- (4- (1- propylbutyl)phenoxy)methyl)phenyl)thiazol- 2- yl)methyl)amino)acetic acidIBA
04/2010
1WW Domain-Containing OxidoreductaseIBA
05/2009
1Acetaminophen (Paracetamol)FDA LinkGeneric
03/2008
1Fatty Acids (Saturated Fatty Acids)IBA
06/2007
1Monensin (Coban)IBA
06/2007
1JTP-426467IBA
09/2006
1Rosiglitazone (Avandia)FDA Link
09/2006
1PPAR gammaIBA
09/2006
1LeptinIBA
09/2006
1Blood Glucose (Blood Sugar)IBA
09/2005

Therapy/Procedure

3Sphincterotomy
10/2009 - 02/2001
3Stents
10/2009 - 09/2001
3Drug Therapy (Chemotherapy)
11/2003 - 10/2000
2Therapeutics
05/2013 - 12/2007
2Colonoscopes
01/2013 - 01/2007
2Decompression
10/2001 - 07/2000
2Intravenous Injections
01/2001 - 11/2000
1Osteotomy
10/2014
1Surgical Instruments (Clip)
01/2013
1Tracheotomy
11/2010
1Choledochostomy
10/2009
1Transplantation
03/2008
1Intraperitoneal Injections
03/2008
1Surgical Portacaval Shunt (Portacaval Anastomosis)
01/2008